Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Platform technologies that can be reused for the manufacture of multiple drug pr...
Biologics manufacturers urged to develop a chemistry, manufacturing, and control...
From cancer therapies to antivirals, ocean-derived drugs hold vast promise—but s...
A new workflow transforms media blending into a practical alternative for screen...
Avenue uses thousands of naturally occurring and engineered signal peptides to m...
In this Thought Leader piece Li Qu, PhD, and Peng Li, PhD, from WuXi AppTec why ...
Immusoft’s autologous immune system programming platform is in the clinic for MP...
What innovations will define the cancer drug delivery landscape in 2026? To find...
How AI, robotics, and modular design are transforming single-cell and spatial bi...
The green shoots suggesting a comeback was in sight for biotech stocks last year...
Stakeholders from across the sector, including manufacturers, technology provide...
2026 will be a pivotal year for biopharma. From digital transformation to an AI ...
Understanding and overcoming these operational and economic hurdles is essential...
When we talk about “autonomous labs,” we are really talking about a new way to d...
Nick Edwards, PhD, CEO of Potato, has a “burning desire” to speed up scientific ...
The results of preclinical research indicate how T cells involved in the immune ...
